Pre-hospital Ventilation Clinical Study

Sponsor
Zoll Medical Corporation (Industry)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05604430
Collaborator
(none)
500
1
24
20.8

Study Details

Study Description

Brief Summary

This study will collect and characterize ventilator use during patient care with a ZOLL 731 Series ventilator in a pre-hospital setting.

Condition or Disease Intervention/Treatment Phase
  • Device: 731 Series Ventilator

Detailed Description

This is a prospective, observational study.

ZOLL will develop a methodology to collect and transfer ventilator data from the device to ZOLL to allow for a characterization of ventilator use in the pre-hospital setting. This knowledge and experience will subsequently be used to inform development of a mechanism to allow for automatic data collection and transmission from ZOLL ventilators to a central data repository. These data will be used to provide feedback, reporting, and benchmarking to individual agencies and departments on their ventilator use as well as aggregate use data from all ventilators to allow for comparisons.

Enrollment in this study is expected to take approximately 24 months. No patient outcome data will be collected.Participants are enrolled once data have been downloaded from the ventilator via RescueNet® VentReview software. Participants will not be followed after the assessment of study objectives.

Study Design

Study Type:
Observational
Anticipated Enrollment :
500 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Pre-hospital Ventilation Clinical Study
Actual Study Start Date :
Jun 30, 2022
Anticipated Primary Completion Date :
Jun 30, 2024
Anticipated Study Completion Date :
Jun 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Ventilator patients

Patients being ventilated by the ZOLL 731 Series ventilator in accordance with device labeling and Agency protocols in a pre-hospital setting.

Device: 731 Series Ventilator
FDA cleared ventilator indicated for use in the management of acute or chronic respiratory failure or during resuscitation.

Outcome Measures

Primary Outcome Measures

  1. Ventilator modes used [Through study completion, an average 1 hour]

    Characterizing how often ventilator modes are used during mechanical ventilation

  2. Ventilator settings used [Through study completion, an average 1 hour]

    Characterizing how often ventilator settings are changed during mechanical ventilation

  3. Ventilator Alarm type [Through study completion, an average 1 hour]

    Characterize type of alarms triggered during mechanical ventilation

  4. Ventilator Alarm Frequency [Through study completion, an average 1 hour]

    Characterize frequency of alarms triggered during mechanical ventilation

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Candidates for this study must meet all of the following Inclusion criteria:
  1. Ventilated using ZOLL 731 Series ventilator with Release 5 (or greater) software

  2. Data recorded in ventilator data file

Exclusion Criteria:
  • None

Contacts and Locations

Locations

Site City State Country Postal Code
1 East Baton Rouge EMS Baton Rouge Louisiana United States 70807

Sponsors and Collaborators

  • Zoll Medical Corporation

Investigators

  • Principal Investigator: Dan Godbee, MD, East Baton Rouge EMS

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zoll Medical Corporation
ClinicalTrials.gov Identifier:
NCT05604430
Other Study ID Numbers:
  • 76701
First Posted:
Nov 3, 2022
Last Update Posted:
Nov 3, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Keywords provided by Zoll Medical Corporation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 3, 2022